Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CypH-11 is a topical, near-infrared pH-responsive fluorogenic dye developed as a sprayable probe for real-time fluorescence-guided surgery. It exhibits minimal fluorescence at neutral pH but fluoresces brightly in acidic environments, which are characteristic of cancer cell proliferation. This property enables surgeons to visualize and highlight cancerous tissues during operations, particularly in the abdominal cavity, facilitating more complete tumor resection while sparing normal tissue. The dye acts rapidly after topical application—fluorescence develops within a minute—enabling the "spray-and-see" approach for identifying small or residual tumors in real time without systemic toxicity. CypH-11 is being developed primarily for use in colorectal, ovarian (including high-grade serous ovarian cancer), and brain cancers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CypH-11.